Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is the most common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. It is important that all stakeholders be involved in tackling the public health threat of obesity and obesity-related diseases, including MASLD. A simple and clear assessment and referral pathway using non-invasive tests is essential to ensure that patients with severe MASLD are identified and referred to specialist care, while patients with less severe disease remain in primary care, where they are best managed. While lifestyle intervention is the cornerstone of the management of patients with MASLD, cardiovascular disease risk must be properly assessed and managed because cardiovascular disease is the leading cause of mortality. No pharmacological agent has been approved for the treatment of MASLD, but novel anti-hyperglycemic drugs appear to have benefit. Medications used for the treatment of diabetes and other metabolic conditions may need to be adjusted as liver disease progresses to cirrhosis, especially decompensated cirrhosis. Based on non-invasive tests, the concepts of compensated advanced chronic liver disease and clinically significant portal hypertension provide a practical approach to stratifying patients according to the risk of liver-related complications and can help manage such patients. Finally, prevention and management of sarcopenia should be considered in the management of patients with MASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The growing yearly prevalence of Metabolic Dysfunction–non-alcoholic fatty liver disease (MASLD) has emerged as a worldwide public health concern, driven by improved living conditions, evolving lifestyle habits, and the widespread occurrence of obesity, diabetes, and metabolic syndrome.1”
From The Impact of Omega-3 Fatty Acids on Triglyceride Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis of Randomized Controlled Trials with Subgroup Analysis by Diabetes Status (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is because the clinical definition of MASLD, as previously noted, includes not only the presence of steatosis but also a cardiometabolic context [31,32,33], which cannot be fully reproduced in a monoculture of hepatocyte-like cells.”
From The HepG2 Cell Line as a Model for Studying Metabolic Dysfunction-Associated Steatotic Liver Disease (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 2×
“102 Of late, there is a growing interest in studies on the association between sarcopenia and MASLD.”
BackgroundEASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Cited by
Items 101–200 of 784
Zhang, Q., Wang, Y., Liu, S., Zhu, S., Peng, L., & Wu, S. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.11.002 · Cited by 16
Reytor-González, C., Annunziata, G., Campuzano-Donoso, M., Morales-López, T., Basantes-Tituaña, C., Fascì-Spurio, F., Verde, L., Muscogiuri, G., Barrea, L., Frías-Toral, E., et al. (2025) · Minerva Endocrinology · doi:10.23736/s2724-6507.24.04314-8 · Cited by 25
Qiu, Y., Laguna, J. C., Alegret, M., & Vilà, L. (2026) · Nutrients · doi:10.3390/nu18040679 · Cited by 16
Modulation of Δ5- and Δ6-desaturases in the brain-liver axis
Zúñiga‐Hernández, J., Farías, C., Espinosa, A., Mercado, L., Dagnino‐Subiabre, A., del Campo, A., Illesca, P., Videla, L. A., & Valenzuela, R. (2024) · Nutrition · doi:10.1016/j.nut.2024.112629 · Cited by 14
Ye, L., Yan, K., Tian, Z., Xiao, Z.-H., Xie, R.-Y., Xie, Z., & Tao, L. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i13.102563 · Cited by 13
Association between arterial stiffness and MASLD in US young adults: base on NHANES 2005-2018
Li, Q., Tan, J.-X., Qin, Q.-Z., Ruan, G., Deng, T., & Gong, Y.-Z. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101003 · Cited by 15
Therapeutic Potential of Short-Chain Fatty Acids in Gastrointestinal Diseases
Zhu, M., & Lee, J. W. J. (2025) · Nutraceuticals · doi:10.3390/nutraceuticals5030019 · Cited by 16
Tomaszewska, A., Gonciarz, W., Rechciński, T., Chmiela, M., Kurdowska, A., & Krupa, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-56308-7 · Cited by 14
Zhang, F., Liu, L., & Li, W. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01081-0 · Cited by 16
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease
Acierno, C., Nevola, R., Rinaldi, L., Sasso, F. C., Adinolfi, L. E., & Caturano, A. (2025) · Livers · doi:10.3390/livers5020017 · Cited by 16
Cueto-Galán, R., Fontalba-Navas, A., Gutiérrez‐Bedmar, M., Ruiz‐Canela, M., Martínez‐González, M. Á., Alves, L., Babió, N., Fitó, M., Ros, E., Fiol, M., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1518082 · Cited by 16
Curci, R., Bonfiglio, C., Franco, I., Bagnato, C. B., Verrelli, N., & Bianco, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133772 · Cited by 15
Chan, H. L., Hu, Y., Malinowsky, K., Madin, K., Kroeniger, K., Hou, J., & Sharma, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-80257-w · Cited by 13
Ma, G., Xu, G., & Huang, H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01577-z · Cited by 14
Zhang, X., & Nguyen, M. H. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156190 · Cited by 14
Xie, C., Chen, X., Zhang, J., Jiang, X., Xu, J., & Lin, H. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03833-y · Cited by 15
Bansal, B., Lajeunesse‐Trempe, F., Keshvani, N., Lavie, C. J., & Pandey, A. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.04.012 · Cited by 28
Molecular insights into herbal medicines for the treatment of metabolic associated Steatohepatitis
Addissouky, T. A. (2025) · Discover Chemistry. · doi:10.1007/s44371-025-00212-0 · Cited by 14
Lopes, M. A., Oliveira, E. C. S., Quaglio, A. E. V., Santos, A., Imbrizi, M. R., Mendes, L. E. R., Beraldo, R. F., Baima, J. P., Spiller, A. L., Magro, D. O., et al. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i9.109035 · Cited by 15
Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma
Hussain, M. M., Bi, F., Wang, J., Zhai, A., Li, F., & Hu, H. (2025) · Cancer Medicine · doi:10.1002/cam4.71330 · Cited by 15
Yin, J., Yang, T., Yang, B., Hou, C.-X., Li, J., Li, Y., & Wang, Q. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i18.2440 · Cited by 12
Joung, H., Chu, J., Kwon, Y. J., Kim, K. H., Shin, C. H., & Ha, J. (2024) · Applied Biological Chemistry · doi:10.1186/s13765-024-00949-9 · Cited by 11
Role of Complement in Liver Diseases
Prado, L. G., & Nagy, L. E. (2024) · Seminars in Liver Disease · doi:10.1055/s-0044-1795143 · Cited by 13
Lean MASLD and Cardiovascular Disease: A Review
Lebovics, N., Heering, G., Frishman, W. H., & Lebovics, E. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000893 · Cited by 13
Abenavoli, L., Scarlata, G. G. M., Borelli, M., Suraci, E., Marasco, R., Imeneo, M., Spagnuolo, R., & Luzza, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092973 · Cited by 13
Zhang, J., Wang, S., Zhang, T., Zi, M., Wang, S., & Zhang, Q. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02596-5 · Cited by 16
Xu, B., Liu, X., Pi, Y., & Li, K. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1568211 · Cited by 16
Zhang, S., Liang, H., Liu, J., Huang, Z., Shi, X., & Zhu, Y. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06120-3 · Cited by 11
Baumert, B. O., Maretti-Mira, A. C., Walker, D. I., Li, Z., Stratakis, N., Wang, H., Zhao, Y., Fischer, F. C., Jia, Q., Valvi, D., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01168-z · Cited by 13
Lin, Z., Shi, Y.-Y., Yu, L.-Y., Ma, C.-X., Pan, S., Dou, Y., Zhou, Q., & Cao, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1400741 · Cited by 13
Common Denominator of MASLD and Some Non-Communicable Diseases
Ferenc, K., Jarmakiewicz-Czaja, S., Sokal-Dembowska, A., Stasik, K., & Filip, R. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46070399 · Cited by 11
Bano, S., Copeland, M. A., Stoops, J. W., Orr, A. V., Jain, S., Paranjpe, S., Mooli, R. G. R., Ramakrishnan, S. K., Locker, J. D., Mars, W. M., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101380 · Cited by 11
Hefer, M., Petrovic, A., Kuna, L., Kolarić, T. O., Kizivat, T., Wu, C. H., Tabll, A. A., Smolić, R., Včev, A., & Smolić, M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46080531 · Cited by 11
Kim, D., Cholankeril, G. T., & Ahmed, A. (2024) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes24005 · Cited by 13
Mechanosensing by Piezo1 in gastric ghrelin cells contributes to hepatic lipid homeostasis in mice
Zhang, J., Zhao, Y., Wu, S., Han, M., Gao, L., Yang, K., Chen, H., Wang, C., & Xu, G. (2024) · Science Signaling · doi:10.1126/scisignal.adq9463 · Cited by 10
Sharma, J., & Dey, P. (2024) · Molecular Omics · doi:10.1039/d4mo00140k · Cited by 12
Dallio, M., Romeo, M., Nardo, F. D., Vaia, P., Napolitano, C., Ventriglia, L., Coppola, A., Silvestrin, A., Olivieri, S., & Federico, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020761 · Cited by 10
Chen, J., Wang, P., Li, Z. B., Wu, J., Tang, F., Yang, N., Cen, B., Xie, C., Yang, Y., Yang, Z., et al. (2025) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2025.01.019 · Cited by 11
Alqahtani, S. A., AlAhmed, R. S., AlOmaim, W. S., Alghamdi, S. A., Al-hamoudi, W., Bzeizi, K. I., Albenmousa, A. H., Aghemo, A., Pugliese, N., Hassan, C., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317929 · Cited by 10
Wu, Y., Zheng, G., Zhang, F., & Li, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1544917 · Cited by 13
Zhao, D., Zheng, X., Wang, L., Xie, Y., Chen, Y., & Zhang, Y. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00903-6 · Cited by 12
Alnees, M., Awwad, M., Najajra, D., Darwish, A., Heih, O. Q., AL-Ali, T. K. H., Hamdeh, N. A., Abdullah, A., Ahmad, J., Jarrar, K. S., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04156-8 · Cited by 13
You, Y., Ni, H., Ma, Q., Jiang, L., Cai, J., He, W., Lin, X., Li, K., Wang, Z., Yan, W., et al. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00391-w · Cited by 15
Iwamoto, Y., Kimura, T., Dan, K., Iwamoto, H., Sanada, J., Fushimi, Y., Katakura, Y., Shimoda, M., Nogami, Y., Shirakiya, Y., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15548 · Cited by 12
Wang, T., Wang, D., Kuang, G., Gong, X., Zhang, L. R., Wan, J., & Li, K. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.03.014 · Cited by 11
Fotakis, C., Amanatidou, A. I., Kafyra, M., Andreou, V., Kalafati, I. P., Zervoú, M., & Dedoussis, G. V. (2024) · Nutrients · doi:10.3390/nu16081235 · Cited by 9
Sartorio, A., Pont, C. D., & Romano, S. L. (2024) · Nutrients · doi:10.3390/nu16101471 · Cited by 9
Saito, T., Tsuchishima, M., Tsutsumi, M., & George, J. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18491 · Cited by 14
Free-breathing MRI techniques for fat and R2* quantification in the liver
Shih, S., & Wu, H. H. (2024) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-024-01187-2 · Cited by 17
Yuan, C., Zhang, C., Geng, X., Feng, C., Su, Y., Wu, Y., Wang, Y., Chen, L., Ding, Q., Voortman, T., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-20663-x · Cited by 11
Romano, J., Burnside, J., Sebastiani, G., Ramji, A. S., Patel, K., Swain, M. G., & Saeed, S. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101757 · Cited by 13
El‐Ashmawy, N. E., Al‐Ashmawy, G. M., Kamel, A. A., & Khedr, E. G. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167666 · Cited by 10
Romeo, M., Dallio, M., Cipullo, M., Coppola, A., Mazzarella, C., Mammone, S., Iadanza, G., Napolitano, C., Vaia, P., Ventriglia, L., et al. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf001 · Cited by 13
Donghia, R., Bonfiglio, C., Giannelli, G., & Tatoli, R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14061950 · Cited by 11
Noguchi, D., Hayasaki, A., Ito, T., Iizawa, Y., Fujii, T., Tanemura, A., Murata, Y., Kuriyama, N., Kishiwada, M., & Mizuno, S. (2025) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.12145 · Cited by 9
Li, Q., Gao, Y., Wang, D., Zhu, X., Jia, J., Liu, L.-L., Tian, H., Wang, L., Zhang, Y., & Zhang, D. (2025) · Academic Radiology · doi:10.1016/j.acra.2025.04.009 · Cited by 11
Ramesh, D., Manickavel, P., Ghosh, S., & Bhat, M. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.102611 · Cited by 11
Metabolic dysfunction-associated steatotic liver disease
Hsu, C., & Alazawi, W. (2025) · Clinical Medicine · doi:10.1016/j.clinme.2025.100526 · Cited by 14
Kim, J., Sim, Y., Kim, D.-H., Kwon, J., Lee, S., Rungratanawanich, W., Kim, J., Jung, J., Lee, Y., Hyun, S., et al. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101105 · Cited by 20
Bian, H., Ma, J., Qu, S., Qian, J., Hao, C., Liu, C., & Gao, X. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-10013-6 · Cited by 12
Chen, J., Liang, Q., Chen, Z., Liu, W., Chen, X., Li, H., Huang, D., Zhou, S., Chen, R., Ren, J., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1757164 · Cited by 9
Parizad, R., Hatwal, J., Brar, A. S., Alizadeh, L., Goyal, M. K., Batta, A., & Mohan, B. (2026) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v15.i1.111030 · Cited by 9
Huang, Z. P., Sung, H. K., Yan, X., He, S., Jin, L., Wang, Q., Wu, X., Hsu, H. H., Pignalosa, A., Crawford, K. S., et al. (2024) · Clinical and Translational Science · doi:10.1111/cts.13760 · Cited by 9
Wang, S.-W., Chang, Y., Wang, C., Cheng, Y., Hsieh, T.-H. J., Wang, C., & Kao, J. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i12.1429 · Cited by 9
Liu, S., Li, F., Cai, Y., Sun, L., Ren, L., Yin, M., Cui, H., Pan, Y., Gang, X., & Wang, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-94118-7 · Cited by 10
Comi, L., Giglione, C., Klinaku, F. T., Pialorsi, F., Tollemeto, V., Zurlo, M., Seneci, A., & Magni, P. (2024) · Food Frontiers · doi:10.1002/fft2.535 · Cited by 8
Zeng, J., Way, G. W., Wu, N., Jiang, X., Tai, Y., Zhao, D., Su, L., Yan, Q., Wang, X., Gurley, E. C., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01362-5 · Cited by 12
Tang, X., Alloosh, M., Ou, Q., Luo, L., Agrawal, D. K., Kalra, D. K., Sturek, M. S., & Bolli, R. (2025) · Basic Research in Cardiology · doi:10.1007/s00395-025-01112-1 · Cited by 11
Calorie-restriction treatment mitigates the aging in rat liver model
Urlandini, L., Leonetti, A. E., Conforti, F., Perri, A., Lofaro, D., Antonucci, G., Mandalà, M., Bossio, S., Agostino, S. D., & Rago, V. (2025) · Biogerontology · doi:10.1007/s10522-025-10245-8 · Cited by 8
Kumar, R., Chinala, A., Grandhe, D., Endicott, S. J., Garcia, M. A., Campen, M. J., & Gullapalli, R. R. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.126844 · Cited by 9
Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease
Rodríguez, S., Dahlem, M. L. F., Rossoni, C., Marroni, N. P., Marroni, C. A., & Fernandes, S. A. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i8.108182 · Cited by 8
Marrone, A., Allosso, F., Caturano, A., Selvaggio, L. D., Errico, M., Grande, G., Navarra, R., Ludovico, C. D., Montagna, M. L., Sasso, F. C., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf479 · Cited by 9
Gut microbial signatures associated with the Indian lean MASLD phenotype
Dey, P. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1673517 · Cited by 8
Morawska, A., Frankowski, R., Grabarczyk, M., Kosmalski, M., & Różycka-Kosmalska, M. (2025) · Life · doi:10.3390/life15111713 · Cited by 13
Purnomo, H. D., Adiwinata, R., Permatadewi, C. O., Hutami, H. T., & Indiarso, D. (2025) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2025.1699508 · Cited by 9
Yamagata, M., Tsuchishima, M., Saito, T., Tsutsumi, M., & George, J. (2024) · Clinical Science · doi:10.1042/cs20230533 · Cited by 8
Sun, M., Qiu, Y., Zhang, L., & Chen, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-74791-w · Cited by 10
Bonfiglio, C., Tatoli, R., Donghia, R., Guido, D., & Giannelli, G. (2024) · Antioxidants · doi:10.3390/antiox13111286 · Cited by 11
Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Thyroid Cancer
Moon, S. Y., Son, M., Cho, J. H., Kim, H. I., Han, J. M., Bae, J. C., & Suh, S. (2024) · Thyroid · doi:10.1089/thy.2024.0522 · Cited by 11
Gao, J. S., Wilde, B., Kripfgans, O. D., Chen, J., & Rubin, J. M. (2025) · Journal of Ultrasound in Medicine · doi:10.1002/jum.16669 · Cited by 10
Khalil, M., Abdallah, H., Jaber, N., Garruti, G., Ciaula, A. D., & Portincasa, P. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.08.014 · Cited by 9
Rossi, F. A. M., Agudelo, J. S., Castro, N. I. Q., Mosquera, S. Z., Fajardo, M. C. M., López, E. D. M., Olarte, J. D. E., Medina, M. A. F., Simancas, E. Z., & Osuna, L. F. S. (2024) · Cureus · doi:10.7759/cureus.63019 · Cited by 8
Dai, R., Sun, M., Lu, M., & Deng, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34150 · Cited by 8
Baker, F. A., Zeina, A., Taher, R., Mouch, S. A., & Israel, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185608 · Cited by 7
Xi, J., Wang, Y., Li, X., Sun, N., Ming, R., Yan, H., Cai, H., Bai, J., Xiang, Y., Gu, J., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16289 · Cited by 8
Fu, J., Liu, C., Yang, L., Zhang, B., Zhou, R., Deng, C., Zhang, H., Kong, J., Li, J., & Shi, J. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002964 · Cited by 10
Boonkaew, B., Satthawiwat, N., Pachane, B. C., Brett, L. M., Tangkijvanich, P., & Ariyachet, C. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2025.04.007 · Cited by 9
Zhang, F., Lo, E. K. K., Chen, C., Lee, J. C., Felicianna, Ismaiah, M. J., Leung, H. K. M., Tsang, D., & El-Nezami, H. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10593-4 · Cited by 10
Zhou, T., & Xie, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-03453-2 · Cited by 8
Banerjee, M., Pal, R., & Pal, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70187 · Cited by 9
CD47: an immunoregulatory nexus in liver and gastrointestinal disorders
Otuagomah, J., Newcomb, A., Gwag, T., & Wang, S. (2025) · eGastroenterology · doi:10.1136/egastro-2025-100242 · Cited by 8
de Souza, N. S., Vitório, T. C. V., de Souza, R. A., Machado, M. A. D., & Cotrim, H. P. (2026) · Diagnostics · doi:10.3390/diagnostics16020261 · Cited by 9
Fajkić, A., Jahić, R., Hadžović-Džuvo, A., & Lepara, O. (2024) · Cureus · doi:10.7759/cureus.55673 · Cited by 10
Reyes-Avendaño, I., Villaseñor-Altamirano, A. B., Reyes-Jiménez, E., Velázquez-Enríquez, J. M., Baltiérrez‐Hoyos, R., Piña‐Vázquez, C., Muriel, P., Villa‐Treviño, S., Arellanes‐Robledo, J., & Vásquez-Garzón, V. R. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.05.010 · Cited by 7
Sinha, R. A. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2068 · Cited by 10
Dallio, M., Romeo, M., Nardo, F. D., Napolitano, C., Vaia, P., Iadanza, G., Olivieri, S., Coppola, A., Niosi, M., & Federico, A. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01074-z · Cited by 10
Insights Into Intestinal Flora in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Xin, Z., Wang, Z., & Chu, M. (2025) · The FASEB Journal · doi:10.1096/fj.202403293rr · Cited by 8
Position paper on perioperative management and surgical risk in the patient with cirrhosis
Velasco, J. A. V.-R., Crespo, J., Montaño‐Loza, A. J., Aldana-Ledesma, J. M., Cano-Contreras, A. D., Reyes, E. C., Pérez, N. J. F., Castro‐Narro, G., García-Jiménez, E. S., Lira-Vera, J. E., et al. (2024) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2024.05.001 · Cited by 7
Xia, T., Ni, J., Ni, Y., Wu, X., Du, K., Wan, X., & You, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1454193 · Cited by 8
Lee, J., So, J., Han, C. I., Yang, H., Sung, P. S., Bae, S. H., & Song, D. S. (2024) · Hepatology International · doi:10.1007/s12072-024-10737-8 · Cited by 8
Metadata
- Authors
- Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R.
- Affiliations
- University of Malaya (MY)
- Chinese University of Hong Kong (HK)
- Corresponding author
- Chan, Wah-Kheong
- Venue
- Journal of Obesity & Metabolic Syndrome
- Published
- 2023-09-13
- Volume
- 32
- Issue
- 3
- Pages
- 197-213
- ISSN
- 2508-6235 (ISSN-L)
- 2508-7576
- PMC
- PMC10583766
- OpenAlex
- W4386704735
- Cited by
- 776
- References
- 122
- Citations by year
- 2026: 245 · 2025: 342 · 2024: 183 · 2023: 5
- FWCI
- 30.29
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Journal of Obesity & Metabolic Syndrome (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- non-alcoholic fatty liver disease, metabolic syndrome, obesity, chronic liver disease, non-invasive liver assessment, referral pathways, lifestyle intervention, cardiovascular risk, anti-hyperglycemic drugs, liver cirrhosis, decompensated cirrhosis, compensated advanced chronic liver disease, clinically significant portal hypertension, sarcopenia, liver complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.